When using this form of gene editing, Cedars-Sinai scientists can more efficiently insert reporter genes that glow when a stem cell turns into a specific cell of the body. 5 billion cells of the heart.
The team foresees their findings being implemented in the regrowth of cells lost during heart attack. And this might tremendously benefit the patients who undergo these kinds of procedures.
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions.
Perhaps the most important potential application of stem cells is the generation of cells and tissues.
For their research, Alexander and his colleagues searched for polymers found in human pluripotent stem cells that can be grown at a rate of billions at a time.
Funding for the research came from the MRC, the UK Regenerative Medicine Platform and the Wellcome Trust. “What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective”, said one of the lead researchers Morgan Alexander, professor of biomedical surfaces at University of Nottingham.
During a $3.68 million study, researchers were able to develop a material that is not variable or contaminable, and it is scalable – meaning affordable stem cell-based treatments could be mounted within a short time.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
These new materials have shown great promise in the laboratory. This could potentially allow the development of stem cell based treatments both affordable and fast. Stem cells are highly efficient in treatments for diabetes, Alzheimer’s disease, spinal cord injury fix, baldness reversal and the list can go on with Parkinson’s disease and spinal cord injury fix.
Denning predicts that synthetic stem cell growing material could be used to help patients in as little as two or three years.
Conditions of the heart, liver, and brain are all under investigation as possible new stem cell treatments.
“The combination of low-dose irradiation and correct gene copy will accelerate our ability to model human disease using stem cells from patients with many different disorders”, said co-senior author Vaithilingaraja Arumugaswami, MVSc, PhD, director of the Pancreas and Liver Program in the Cedars-Sinai Board of Governors Regenerative Medicine Institute.
by Chad Weber